首页> 外文期刊>Addiction biology >Atypical development of behavioural sensitization to 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') in adolescent rats and its expression in adulthood: role of the MDMA chirality.
【24h】

Atypical development of behavioural sensitization to 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') in adolescent rats and its expression in adulthood: role of the MDMA chirality.

机译:在青春期大鼠中对3,4-亚甲二氧基甲基苯丙胺(MDMA,'摇头丸')行为致敏的非典型发展及其在成年期的表达:MDMA手性的作用。

获取原文
获取原文并翻译 | 示例
       

摘要

Despite the great popularity of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) as a drug of abuse, not much is known about the detailed mechanisms of the acute and subchronic effects of the drug. There is especially a lack of information about the distinct behavioural effects of its optical isomers (enantiomers) R- and S-MDMA compared with the racemic RS-MDMA. For this purpose, adolescent rats were repetitively treated during two treatment stages (stage 1: days 1-10; stage 2: days 15, 17, 19) with RS-MDMA (5 or 10 mg/kg) or each of the respective enantiomers (5 mg/kg). The repeated treatment started on postnatal day (PND) 32 and locomotor activity was measured on each day by means of a photobeam-equipped activity box system. RS-MDMA or S-MDMA administration led acutely to massive hyperlocomotion and subchronically, to the development of behavioural sensitization after a short habituation period. R-MDMA was free of hyperactivating effects and even decreased locomotor behaviour upon repeated treatment. Nevertheless, co-administration of R-MDMA increased the hyperactivity of S-MDMA and made the S-MDMA induced behavioural sensitization state-dependent. The animals pre-treated with R-MDMA showed a sensitized response in adulthood when tested with RS-MDMA. Our results indicated that even in the absence of substantial neurotoxicity, both MDMA enantiomers can lead to long-term changes in brain circuitry and concomitant behavioural changes when repeatedly administered in adolescence. The sensitization development was most pronounced in the animals treated with S- and RS-MDMA; the animals with R-MDMA did not develop sensitization under repeated treatment but expressed a sensitized response when challenged with RS-MDMA.
机译:尽管3,4-亚甲二氧基甲基苯丙胺(摇头丸,摇头丸)作为滥用药物非常受欢迎,但对该药物的急性和亚慢性作用的详细机制知之甚少。与外消旋RS-MDMA相比,尤其缺乏关于其旋光异构体(对映异构体)R-和S-MDMA的独特行为影响的信息。为此,在两个治疗阶段(第1阶段:第1-10天;第2阶段:第15、17、19天)分别用RS-MDMA(5或10 mg / kg)或每种对映体重复治疗青春期大鼠(5 mg / kg)。重复治疗始于出生后第32天(PND),每天通过配备有光束的活动盒系统测量运动能力。 RS-MDMA或S-MDMA的使用会导致急性超大规模运动,并在较短的适应期后导致亚慢性行为敏化的发展。 R-MDMA在重复治疗后没有过度激活作用,甚至没有运动行为。然而,R-MDMA的共同给药增加了S-MDMA的过度活跃,并使S-MDMA诱导的行为致敏状态依赖。用RS-MDMA进行预处理时,用R-MDMA预处理的动物在成年后表现出敏感反应。我们的研究结果表明,即使在没有实质性神经毒性的情况下,两种MDMA对映异构体在青春期重复给药时也可导致脑回路的长期变化和伴随的行为变化。在用S-和RS-MDMA处理的动物中,致敏作用发展最为明显。具有R-MDMA的动物在反复治疗下未出现致敏作用,但在受到RS-MDMA攻击时表现出致敏反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号